# Increased Re-eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Triple Therapy

> **NCT01572597** · PHASE4 · UNKNOWN · sponsor: **Buddhist Tzu Chi General Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Bacterial Infection Due to Helicobacter Pylori (H. Pylori)

## Interventions

- **DRUG:** 10RAC+acetylcystein
- **DRUG:** 10RAC+metronidazole

## Key facts

- **NCT ID:** NCT01572597
- **Lead sponsor:** Buddhist Tzu Chi General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-06
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2012-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01572597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01572597, "Increased Re-eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Triple Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01572597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*